Status | Study |
Terminated |
Study Name: Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload Condition: Iron Overload Accelerated Phase Chronic Myelogenous Leukemia Date: 2010-07-06 Interventions: Drug: deferasirox Given orally Other Names: |
Terminated |
Study Name: Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2010-02-24 Interventions: Drug: plerixafor Given SC |
Active, not recruiting |
Study Name: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Undifferentiated Leukemia Date: 2010-01-20 Interventions: Procedure: massage therapy Und |
Recruiting |
Study Name: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Condition: Acute Undifferentiated Leukemia Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Date: 2009-05-09 Interventions: Other: cytology specimen collection procedure Correlative studies |
Completed |
Study Name: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2009-04-29 Interventions: Drug: sunitinib malate Given P |
Active, not recruiting |
Study Name: Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2009-03-04 Interventions: Drug: fludarabine phosphate Gi |
Completed |
Study Name: Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2008-11-26 Interventions: Other: internet-based intervention |
Completed |
Study Name: Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2008-11-20 Interventions: Drug: ondansetron Given IV |
Terminated |
Study Name: Aflibercept in Treating Patients With Myelodysplastic Syndromes Condition: Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Myelomonocytic Leukemia Date: 2007-07-30 Interventions: Biological: ziv-aflibercept Gi |
Completed |
Study Name: Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Condition: Hematopoietic/Lymphoid Cancer Accelerated Phase Chronic Myelogenous Leukemia Date: 2007-06-20 Interventions: Drug: beclomethasone dipropionate |